Millennium Management’s Intersect ENT, Inc XENT Stock Holding History
Bought
Maintained
Sold
Millennium Management's XENT Position: Q2 2022 in Review
Millennium Management sold out of Intersect ENT, Inc (XENT) in Q2 2022, closing a stake of 510,536 shares — an estimated $14.3M sold.
Millennium Management first reported a position in XENT in Q3 2014 and held it in 25 quarters. The position peaked at $43.1M in Q1 2019. 0 funds tracked by Wall St. Rank hold XENT as of Q2 2022.
- Millennium Management reported no remaining Intersect ENT, Inc position as of Q2 2022 after selling out during the quarter.
- Millennium Management sold 510,536 Intersect ENT, Inc shares in Q2 2022, an estimated $14.3M.
- Millennium Management first reported a position in Intersect ENT, Inc in Q3 2014 and held it in 25 quarters.
- Millennium Management's Intersect ENT, Inc position peaked at $43.1M in Q1 2019.
- 0 funds tracked by Wall St. Rank held Intersect ENT, Inc as of Q2 2022.
Based on Millennium Management's 13F filing for Q2 2022, filed 15 Aug 2022.